This finding supports a previous report that during inflammation of the intestinal mucosa in IBD, superoxide and reactive oxygen intermediates act as antimicrobial agents and also induce oxidative stress, hypoxia, and HIF-1a activation, which in turn induces a metabolic shift towards glycolysis and initiates angiogenesis [50,54]. Here, HIF1A is linked to inflammatory bowel disease.